Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 2, 2009, Pages 105-109

  Aksoy, Hulya ^a   Aksoy, Ayse Nur ^b   Ozkan, Asuman ^c   Polat, Harun ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Erzurum Nenehatun Obstetrics and Gynecology Hospital   (Turkey)

^c State Hospital   (Turkey)

Author keywords

Hyperemesis gravidarum; MDA; PON; Serum lipids; TAO

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; HYPEREMESIS GRAVIDARUM; LIPID BLOOD LEVEL; OXIDATIVE STRESS; PREGNANCY;

ADULT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL; FEMALE; HUMANS; HYPEREMESIS GRAVIDARUM; LIPIDS; LIPOPROTEINS; MALONDIALDEHYDE; OXIDATIVE STRESS; PREGNANCY; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 63149090424     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20298     Document Type: Article

References (25)

1. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993;43:245-248.
2. Fairweather DV. Nausea and vomiting in pregnancy. Am J Obstet Gynecol 1968;102:135-175.
3. Verberg MFG, Gillot DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005;11:527-539.
4. Quinlan JD, Hill DA. Nausea and vomiting of pregnancy. Am Fam Physician 2003;68:121-128.
5. Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab 2007;53:173-177.
6. Ustun Y, Engin-Ustun Y, Dokmeci F, Soylemez F. Serum concentrations of lipids and apolipoproteins in normal and hyperemetic pregnancies. J Matern Fetal Neonatal Med 2004;15:287-290.
7. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-1590.
8. Guney M, Oral B, Mungan T. Serum lipid peroxidation and antioxidant potential levels in hyperemesis gravidarum. Am J Perinatol 2007;24:283-289.
9. Mizumoto Y, Okuyama T, Endo R, et al. Studies on hypogeusia in hyperemesis gravidarum. Nippon Sanka Fujinka Gakkai Zasshi 1994;46:35-41.
10. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-119.
11. Sampson MJ, Braschi S, Willis G, Astley SB. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes. Clin Sci (Lond) 2005;109:189-197.
12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
13. Järnfelt-Samsioe A, Eriksson B, Mattsson LA, Samsioe G. Serum lipids and lipoproteins in pregnancies associated with emesis gravidarum. Gynecol Endocrinol 1987;1:51-60.
14. Morris JM, Gopaul NK, Endresen MJ, et al. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol 1998;105:1195-1199.
15. Fait V, Sela S, Ophir E, et al. Hyperemesis gravidarum is associated with oxidative stress. Am J Perinatol 2002;19:93-98.
16. Frigo P, Lang C, Reisenberger K, Kolbl H, Hirschl AM. Hyperemesis gravidarum associated with Helicobacter pylori seropositivity. Obstet Gynecol 1998;91:615-617.
17. Kocak I, Akcan Y, Ustun C, Demirel C, Cengiz L, Yanik FF. Helicobacter pylori seropositvity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 1999;66:251-254.
18. Aytac S, Turkay C, Kanbay M. Helicobacter pylori stool antigen assay in hyperemesis gravidarum: A risk factor for hyperemesis gravidarum or not? Dig Dis Sci 2007;52:2840-2843.
19. Karadeniz RS, Ozdegirmenci O, Altay MM, et al. Helicobacter pylori seropositivity and stool antigen in patients with hyperemesis gravidarum. Infect Dis Obstet Gynecol 2006;2006:1-3.
20. Kondo A, Li J, Manabe M, Saito K, Kanno T, Maekawa M. Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations. J Atheroscler Thromb 2003;10:72-78.
21. Klimov AN, Gurevich VS, Nikiforova AA, et al. Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis 1993;100:13-18.
22. Weitman SD, Vodicnik MJ, Lech JJ. Influence of pregnancy on parathion toxicity and distribution. Toxicol Pharmacol 1983;71:215-224.
23. Verit FF, Erel O, Celik H. Paraoxonase-1 activity in patients with hyperemesis gravidarum. Redox Rep 2008;13:134-138.
24. Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
25. Van Lenten BJ, Wagner AC, Navab M, Fogelman AM. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. Biol Chem 2001;276:1923-1929.